| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Şule Bıçakcı Ay, Kader K Oğuz, Elçin Özçelik Eroğlu, Arzu Ceylan Has, Aygün Ertuğru. A diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptoms. Human psychopharmacology. 2022-11-16. PMID:36382404. |
a diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptoms. |
2022-11-16 |
2023-08-14 |
Not clear |
| Maryanne O'Donnell, Scott B Teasdale, Xin-Yi Chua, Jamie Hardman, Nan Wu, Jackie Curtis, Katherine Samaras, Patrick Bolton, Margaret J Morris, Cyndi Shannon Weickert, Tertia Purves-Tyson, Fatima El-Assaad, Xiao-Tao Jiang, Georgina L Hold, Emad El-Oma. The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses. Pathogens (Basel, Switzerland). vol 11. issue 11. 2022-11-11. PMID:36365032. |
this exploratory proof-of-concept study aimed to: (i) characterize the gut microbiota in antipsychotic naïve or quasi-naïve people with first-episode psychosis, and people with established schizophrenia receiving clozapine therapy; (ii) test for microbiome changes following a lifestyle intervention which included diet and exercise education and physical activity. |
2022-11-11 |
2023-08-14 |
human |
| Kyungtae Kim, Yong Sik Kim, Eun-Jeong Joo, Eui-Joong Kim, Soo-Young Bhang, Jae-Won Choi, Jae Hoon Jeong, Kyu Young Le. Clozapine Blood Concentration Predicts Corrected QT-Interval Prolongation in Patients With Psychoses. Journal of clinical psychopharmacology. vol 42. issue 6. 2022-11-10. PMID:36356202. |
clozapine is the only antipsychotic recommended for treatment of resistant schizophrenia; however, clozapine has been reported to cause qtp. |
2022-11-10 |
2023-08-14 |
Not clear |
| Gregory H Jones, Brian G Mitchell, Jared Bernard, Annette Walder, Olaoluwa O Okusag. History of Suicide Attempt and Clozapine Treatment in Veterans With Schizophrenia or Schizoaffective Disorder. The primary care companion for CNS disorders. vol 24. issue 6. 2022-11-07. PMID:36343352. |
history of suicide attempt and clozapine treatment in veterans with schizophrenia or schizoaffective disorder. |
2022-11-07 |
2023-08-14 |
Not clear |
| Raffael Massuda, Clarissa S Gama, Paulo Belmonte-de-Abreu, Helio Elkis, David Freitas de Lucena, Rodrigo Bressan, Cristiano Noto, Ary Gadelh. Clozapine prescription trends in Brazil in the last decade. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). 2022-11-03. PMID:36327429. |
clozapine is a second-generation antipsychotic indicated for treatment-resistant schizophrenia. |
2022-11-03 |
2023-08-14 |
Not clear |
| Raffael Massuda, Clarissa S Gama, Paulo Belmonte-de-Abreu, Helio Elkis, David Freitas de Lucena, Rodrigo Bressan, Cristiano Noto, Ary Gadelh. Clozapine prescription trends in Brazil in the last decade. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). 2022-11-03. PMID:36327429. |
studies in several countries have shown a low rate of clozapine use despite the fact that approximately 30% of schizophrenia cases are treatment-resistant. |
2022-11-03 |
2023-08-14 |
Not clear |
| Marguerite Le Marois, Camille Sanson, Magali-Anne Maizières, Michel Partiseti, G Andrees Bohm. The atypic antipsychotic clozapine inhibits multiple cardiac ion channels. Naunyn-Schmiedeberg's archives of pharmacology. 2022-10-29. PMID:36308551. |
clozapine is an atypical neuroleptic used to manage treatment-resistant schizophrenia which is known to inhibit cardiac herg/k |
2022-10-29 |
2023-08-14 |
Not clear |
| Yuta Kawakita, Masahiro Takeshima, Tomonari Komatsu, Aya Imanishi, Dai Fujiwara, Yu Itoh, Kazuo Mishim. Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study. BMC psychiatry. vol 22. issue 1. 2022-10-22. PMID:36271340. |
relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study. |
2022-10-22 |
2023-08-14 |
Not clear |
| Yuta Kawakita, Masahiro Takeshima, Tomonari Komatsu, Aya Imanishi, Dai Fujiwara, Yu Itoh, Kazuo Mishim. Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study. BMC psychiatry. vol 22. issue 1. 2022-10-22. PMID:36271340. |
clozapine may cause serious side effects despite benefits in patients with schizophrenia. |
2022-10-22 |
2023-08-14 |
Not clear |
| Yuta Kawakita, Masahiro Takeshima, Tomonari Komatsu, Aya Imanishi, Dai Fujiwara, Yu Itoh, Kazuo Mishim. Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study. BMC psychiatry. vol 22. issue 1. 2022-10-22. PMID:36271340. |
thus, an accurate understanding of the side-effect profile of clozapine is extremely important in the management of its administration to patients with schizophrenia. |
2022-10-22 |
2023-08-14 |
Not clear |
| Yuta Kawakita, Masahiro Takeshima, Tomonari Komatsu, Aya Imanishi, Dai Fujiwara, Yu Itoh, Kazuo Mishim. Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study. BMC psychiatry. vol 22. issue 1. 2022-10-22. PMID:36271340. |
our aim was to validate the relationship between clozapine exposure and appendicitis onset in patients with schizophrenia. |
2022-10-22 |
2023-08-14 |
Not clear |
| Paul Crawford, Kendrick V G. Schizophrenia. American family physician. vol 106. issue 4. 2022-10-19. PMID:36260895. |
treatment-resistant schizophrenia should be treated with clozapine. |
2022-10-19 |
2023-08-14 |
Not clear |
| Lingsi Zeng, Honggang Lv, Juan Li, Ranran Xue, Xia Liu, Cong Zhou, Hao Y. Cigarette smoking, coffee consumption, alcohol intake, and clozapine metabolism: A Mendelian randomization study. Frontiers in psychiatry. vol 13. 2022-10-17. PMID:36245885. |
clozapine is an effective antipsychotic medication for patients with treatment-resistant schizophrenia. |
2022-10-17 |
2023-08-14 |
Not clear |
| Correction to "Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series". The Canadian journal of hospital pharmacy. vol 75. issue 4. 2022-10-17. PMID:36246449. |
correction to "amisulpride augmentation of clozapine in clozapine-resistant schizophrenia: a case series". |
2022-10-17 |
2023-08-14 |
Not clear |
| Ming-Huan Zhu, Zhen-Jing Liu, Qiong-Yue Hu, Jia-Yu Yang, Ying Jin, Na Zhu, Ying Huang, Dian-Hong Shi, Min-Jia Liu, Hong-Yang Tan, Lei Zhao, Qin-Yu Lv, Zheng-Hui Yi, Feng-Chun Wu, Ze-Zhi L. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial. Military Medical Research. vol 9. issue 1. 2022-10-17. PMID:36253804. |
although clozapine is an effective option for treatment-resistant schizophrenia (trs), there are still 1/3 to 1/2 of trs patients who do not respond to clozapine. |
2022-10-17 |
2023-08-14 |
Not clear |
| Djenifer B Kappel, Sophie E Legge, Leon Hubbard, Isabella R Willcocks, Kevin S O'Connell, Robert L Smith, Espen Molden, Ole A Andreassen, Adrian King, John Jansen, Marinka Helthuis, Michael J Owen, Michael C O'Donovan, James T R Walters, Antonio F Pardiña. Genomic Stratification of Clozapine Prescription Patterns Using Schizophrenia Polygenic Scores. Biological psychiatry. 2022-10-16. PMID:36244804. |
genomic stratification of clozapine prescription patterns using schizophrenia polygenic scores. |
2022-10-16 |
2023-08-14 |
Not clear |
| Keisuke Takanobu, Naoki Hashimoto, Shuhei Ishikawa, Ichiro Kusum. Combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels. BMJ case reports. vol 15. issue 10. 2022-10-13. PMID:36229076. |
combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels. |
2022-10-13 |
2023-08-14 |
Not clear |
| Keisuke Takanobu, Naoki Hashimoto, Shuhei Ishikawa, Ichiro Kusum. Combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels. BMJ case reports. vol 15. issue 10. 2022-10-13. PMID:36229076. |
clozapine is the only drug with confirmed efficacy for refractory schizophrenia; however, its use is restricted due to the risk of potentially life-threatening side effects, such as agranulocytosis. |
2022-10-13 |
2023-08-14 |
Not clear |
| Keisuke Takanobu, Naoki Hashimoto, Shuhei Ishikawa, Ichiro Kusum. Combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels. BMJ case reports. vol 15. issue 10. 2022-10-13. PMID:36229076. |
although this restriction ensures safety against haematological risks, some patients with refractory schizophrenia who have low neutrophil levels may miss the opportunity to receive clozapine treatment. |
2022-10-13 |
2023-08-14 |
Not clear |
| Keisuke Takanobu, Naoki Hashimoto, Shuhei Ishikawa, Ichiro Kusum. Combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels. BMJ case reports. vol 15. issue 10. 2022-10-13. PMID:36229076. |
we herein report the case of a patient with refractory schizophrenia and low neutrophil levels who was successfully initiated on clozapine treatment after the use of several methods for increasing neutrophil levels. |
2022-10-13 |
2023-08-14 |
Not clear |